
临床进展无创检测肝硬化
脂肪性肝病风险评分:预测肝硬化与肝细胞癌的临床价值综述
By MedXY|2026年9月25日
本综述评估了脂肪性肝病风险评分在预测肝硬化和肝细胞癌中的临床价值,指出SAFE评分在肝硬化预测方面表现更优,而HCC风险预测仍面临挑战。
Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.
You can change your choice at any time.